Lupus Clinical Trials

People with systemic lupus erythematosus or SLE are asked to participate in a research study being conducted by NSLIJHS, Feinstein Institute for Medical Research.

This is approximately a 30 week study. Compensation may be provided for time and travel.

People with systemic lupus erythematosus are asked to participate in a research study being conducted by NorthWell Health, Feinstein Institute for Medical Research

The drug being tested is called belimumab. It is a prescription medicine to treate active systemic lupus erythematosus who are receiving other lupus medicines. The purpose of the study is to find out if belimumab is effective and safe in treating patients with active lupus nephritis who are receiving other ...

People with systemic lupus erythematosus or SLE are asked to participate in a research study being conducted by NSLIJHS, Feinstein Institute for Medical Research.

Lupus nephritis is a severe form of systemic lupus erythematosus (SLE) with active disease in the kidneys. SLE is a complex disease in which the body's own immune system attacks some of the body parts: the skin, the joints, the kidneys, the nervous system, the heart, the lungs and the ...

Cancer is the second-leading cause of death in the United States today. The majority of cancer deaths can be attributed to the metastatic spread of solid tumors to distant organs. Medical progress in the last century has aided in the earlier identification of cancers limited to the primary organ and ...

A clinical research study of an investigational medication for SLE Lupus patients is being held in Tampa.

People with Lupus Nephritis are asked to participate in a research study being conducted by North Shore Long Island Jewish Health System. Patient Inclusion Criteria: You may be eligible to participate in this study if you: Are between the ages of 18 and 75 years Have been diagnosed with Lupus ...

People with Systemic Lupus Erythematosus are asked to participate in a research study of an investigational drug being conducted by North Shore University Hospital. Patient Inclusion Criteria: You may be eligible to participate in this study if you: Are a male or female between the ages of 18 and 55 ...